Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01(E-4) tuberculosis vaccine. Dagnew AF, Noble R, Cinar A, Burhan E, et al. Vaccine 2026;85:128690.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dagnew AF, Noble R, Cinar A, Burhan E, et al. Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01(E-4) tuberculosis vaccine. Vaccine 2026;85:128690.
PMID: 42119392